Yüklüyor......
Virologic Tools for HCV Drug Resistance Testing
Recent advances in molecular biology have led to the development of new antiviral drugs that target specific steps of the Hepatitis C Virus (HCV) lifecycle. These drugs, collectively termed direct-acting antivirals (DAAs), include non-structural (NS) HCV protein inhibitors, NS3/4A protease inhibitor...
Kaydedildi:
| Yayımlandı: | Viruses |
|---|---|
| Asıl Yazarlar: | , |
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
MDPI
2015
|
| Konular: | |
| Online Erişim: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4690865/ https://ncbi.nlm.nih.gov/pubmed/26690198 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/v7122941 |
| Etiketler: |
Etiketle
Etiket eklenmemiş, İlk siz ekleyin!
|